Phio is a preclinical/early-clinical company with no PDUFA on this date; the large move was unrelated to any FDA decision: archive 'CRL' label appears erroneous.
Price into the decision (T-120)
Daily close, T-120 (2/10/25) through T+5. Run-up high $2.96 on 6/10/25, low $1.01 on 4/14/25 (T-120 to T-1). FDA decision 7/28/25. Historical price action, not a forecast.
Decision facts
FDA decision date2025-07-28
Outcome✗ CRL⚠ label corrected
Decision-day move-7.7%
T-120 run-up (low→high)+128.0% ($1.01→$2.96)
CRL reasonPhio is a preclinical/early-clinical company with no PDUFA on this date; the large move was unrelated to any FDA decision: archive 'CRL' label appears erroneous.
ValidationOutcome consistent with price; primary-source verification in progress.
Market-cap tierNano
Cohort decision-day move (history)8.0% median (n=116)
Cohort move is the historical median absolute decision-day move for this market-cap tier across our run-up study. History, not a prediction.